APAC Spatial Genomics & Transcriptomics Market

APAC Spatial Genomics & Transcriptomics Market by Technique (Spatial Transcriptomics (IHC, ISH), Spatial Genomics (FISH, Sequencing)), Product (Instruments, Consumables, Software), Application (Drug Discovery), End User (Biotech, CROs) - Forecast to 2027

Report Code: BT 8532 Jan, 2023, by marketsandmarkets.com

[134 Pages Report] The Asia Pacific spatial genomics & transcriptomics market is projected to reach USD 152 million by 2027 from USD 64 million in 2022, at a CAGR of 18.9% during the forecast period. The key factors driving the growth of the spatial genomics and transcriptomics market in the Asia Pacific are the increasing capital investments, rising use of spatial omics for disease diagnosis, and rising rate in the adoption rate of spatial genomics and transcriptomics in drug discovery & development. However, analytical limitation associated with spatial techniques are expected to restrain market growth to a certain extent.

Attractive Opportunities in the Asia Pacific Spatial Genomics & Transcriptomics Market

APAC Spatial Genomics & Transcriptomics Market

To know about the assumptions considered for the study, Request for Free Sample Report

Asia Pacific Spatial Genomics & Transcriptomics Market Dynamics

DRIVER: Reduced cost of next-generation sequencing

The cost of next-generation sequencing (NGS) is continuing to decline, with Illumina leading the way in making NGS more affordable and accessible. This is expected to create a robust customer base as laboratories of all sizes are now able to adopt NGS. In October 2022, Illumina launched the NovaSeqX series, a quicker and cheaper genomic sequencing platform, in Thailand. The new platform is a significant improvement over the previous models in terms of speed and cost. The NovaSeqX series is expected to minimize the cost of genome sequencing to just USD 200–300 per sample (this excludes costs associated with processing, interpretation, and counseling), down from USD 600. The new platform delivers more than 20,000 whole genomes of high-resolution optics and ultra-high density flow cells per year, which is 2.5 times greater throughput than the previous model. Such developments are expected to increase the accessibility of NGS across Asia Pacific countries, which would expand its applications in the spatial genomics and transcriptomics market.

CHALLENGES: Analytical limitations associated with spatial techniques

The key analytical limitation associated with spatial genomics and transcriptomics is the limited number of genes that can be analyzed in one go. A variety of methods have been commercialized by market players to visualize mRNA sequences on tissue sections. However, the maximum number of different genes that can be analyzed at a time with such techniques is limited. Customers make use of quantitative and sensitive spatial transcriptomic sequencing methods, but only 3 to 4 genes can be analyzed at once. This creates a challenging environment for customers looking to adopt spatial transcriptomics and genomics techniques.

The Spatial Transcriptomics accounted for the largest share of the technique segments in spatial genomics & transcriptomics market in 2022.

Based on technique, the market is categorized into spatial transcriptomics, and spatial genomics analysis. In 2021, the spatial transcriptomics segment accounted for the largest share of the spatial genomics and transcriptomics market. Increasing demand for and high adoption rate of in situ sequencing techniques is expected to drive the growth of the spatial transcriptomics segment during the forecast period.

The Consumables segment dominated the product segment in spatial genomics & transcriptomics market in 2021.

Based on the product, the segment is categorized into consumables, instruments and software. In 2021, the consumables segment dominated the product segment with the highest revenue share. Growing use of consumables for various spatial genomics and transcriptomics applications is estimated to drive the market growth.

In 2021, the translational research segment have generated highest revenue in the application segment for spatial genomics & transcriptomics market.

Based on the application, the Asia Pacific Spatial Genomics & Transcriptomics Market is segmented into translational research, and drug discovery & development. In 2022, the translational research have generated highest revenue in the application segment. The large share of the translational research segment can be attributed to the increasing use of spatial genomics and transcriptomics to determine high-throughput data on the organizational structure of cell content from tissue and cell species.

China was the largest market for Asia Pacific Spatial Genomics & Transcriptomics in 2022.

Geographically, the spatial genomics & transcriptomics market is segmented into Japan, China, India and Rest of Asia Pacific. The spatial genomics & transcriptomics market is dominated by China in 2022 and this dominance is anticipated to continue throughout the forecast period. The large share of the segment can be attributed to the rising incidence of chronic diseases and technological advancements and the launch of cell therapies to treat different cancers in the spatial genomics and transcriptomics market in this region.

APAC Spatial Genomics & Transcriptomics Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Key Market Players

Prominent players in the spatial genomics & transcriptomics market include NanoString Technologies, Inc. (US), 10X Genomics (US), Illumina (US), Bio-Rad Laboratories (US), Bio-Techne Corporation (US), Standard BioTools Inc. (US), Genomic Vision SA (France), Akoya Biosciences, Inc. (US), S2 Genomics (US), Cantata Bio (US), Vizgen Group (US), BGI Group (China), Miltenyi Biotec (Germany), Bruker (US), Perkinelmer Inc. (US), and Novogene Co., Ltd. (China).

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

Report Metric

Details

Market size available for years

2020–2027

Base year considered

2021

Forecast period

2022–2027

Forecast units

Value (USD)

Segments covered

Product, Technique, Application, End User, and Country

Geographies covered

China, India, Japan, and rest of Asia Pacific

Companies covered

NanoString Technologies, Inc. (US), 10X Genomics (US), Illumina (US), Bio-Rad Laboratories (US), Bio-Techne Corporation (US), Standard BioTools Inc. (US), Akoya Biosciences, Inc. (US), PerkinElmer, Inc. (US), S2 Genomics, Inc. (US), Cantata Bio (US), Vizgen Corporation (US), BGI (China), Miltenyi Biotec (Germany), Bruker (US), PerkinElmer Inc. (US), and Novogene Co., Ltd. (China).

This report categorizes the Asia Pacific spatial genomics & transcriptomics market into the following segments:

Asia Pacific Spatial Genomics & Transcriptomics Market, by Technique
  • Spatial Transcriptomics
  • Immunohistochemistry (IHC)
  • In Situ Hybridization
  • Sequencing Techniques
  • Microscopy based RNA imaging
  • Other Spatial Transcriptomics Techniques
  • Spatial Genomics Analysis
  • Immunohistochemistry (IHC)
  • In Situ Hybridization
  • Sequencing Techniques
  • Microscopy based RNA imaging
  • Other Spatial Transcriptomics Techniques
Asia Pacific Spatial Genomics & Transcriptomics Market, by Product
  • Instruments
  • Consumables
  • Software
Asia Pacific Spatial Genomics & Transcriptomics Market, by Application
  • Translational Research
  • Drug Discovery and Development
Asia Pacific Spatial Genomics & Transcriptomics Market, by End User
  • Academic and Research Institutes
  • Contract Research Organization
  • Pharmaceutical and Biotechnology Companies
Asia Pacific Spatial genomics & transcriptomics Market, by Country
  • Asia Pacific (APAC)
    • Japan
    • India
    • China
    • Rest of Asia Pacific (RoAPAC)

Recent Developments

  • In 2022, NanoString and Abcam announced an agreement to co-market Abcam antibodies for NanoString’s high-plex spatial multiomics solutions.
  • In 2022, 10x Genomics announced the first commercial shipments of its Xenium platform for in situ analysis. Xenium is the next generation of targeted spatial profiling of genes and proteins at subcellular resolution.
  • In 2022, Illumina and AstraZeneca announced a strategic research collaboration to accelerate drug target discovery by combining their strengths in AI-based genome interpretation and genomic analysis techniques with industry expertise.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 17)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 STUDY SCOPE 
    1.4 YEARS CONSIDERED 
    1.5 CURRENCY CONSIDERED 
    1.6 LIMITATIONS 
    1.7 STAKEHOLDERS 
 
2 RESEARCH METHODOLOGY (Page No. - 20)
    2.1 RESEARCH DATA 
          FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
                    FIGURE 2 BREAKDOWN OF PRIMARIES: ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET
    2.2 MARKET ESTIMATION METHODOLOGY 
          FIGURE 3 MARKET SIZE ESTIMATION (COMPANY REVENUE ANALYSIS-BASED ESTIMATION)
          FIGURE 4 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET SIZE (USD MILLION)
          FIGURE 5 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: FINAL CAGR PROJECTIONS (2022−2027)
          FIGURE 6 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DEMAND-SIDE DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    2.3 MARKET DATA ESTIMATION AND TRIANGULATION 
          FIGURE 7 DATA TRIANGULATION METHODOLOGY
    2.4 INDUSTRY INSIGHTS 
    2.5 RESEARCH ASSUMPTIONS 
 
3 EXECUTIVE SUMMARY (Page No. - 27)
    FIGURE 8 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
    FIGURE 9 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION)
    FIGURE 10 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
    FIGURE 11 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
    FIGURE 12 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET SHARE, BY COUNTRY, 2021
 
4 PREMIUM INSIGHTS (Page No. - 31)
    4.1 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET OVERVIEW 
          FIGURE 13 REDUCED COST OF NEXT-GENERATION SEQUENCING TO DRIVE MARKET GROWTH
    4.2 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET SHARE, BY PRODUCT (2021) 
          FIGURE 14 CONSUMABLES SEGMENT DOMINATED MARKET IN JAPAN
    4.3 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET SHARE, BY APPLICATION (2021) 
          FIGURE 15 TRANSLATIONAL RESEARCH SEGMENT DOMINATED MARKET IN CHINA
 
5 MARKET OVERVIEW (Page No. - 33)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 16 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
          TABLE 1 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: IMPACT ANALYSIS
           5.2.1 DRIVERS
                    5.2.1.1 Reduced cost of next-generation sequencing
                    5.2.1.2 Increasing adoption of spatial genomics and transcriptomics in drug discovery and development
           5.2.2 RESTRAINTS
                    5.2.2.1 High capital investments
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Increasing demand for single-cell analysis
           5.2.4 CHALLENGES
                    5.2.4.1 Analytical limitations associated with spatial techniques
    5.3 TECHNOLOGY ANALYSIS 
          TABLE 2 FIVE BENCHMARK COMPUTATIONAL METHODS: COMPARATIVE ANALYSIS
    5.4 VALUE CHAIN ANALYSIS 
          TABLE 3 INDICATIVE LIST OF DISTRIBUTORS FOR KEY MARKET PLAYERS IN ASIA PACIFIC
          FIGURE 17 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: VALUE CHAIN ANALYSIS
    5.5 ECOSYSTEM ANALYSIS 
          FIGURE 18 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: ECOSYSTEM ANALYSIS
    5.6 PORTER’S FIVE FORCES ANALYSIS 
          TABLE 4 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.6.1 THREAT OF NEW ENTRANTS
           5.6.2 THREAT OF SUBSTITUTES
           5.6.3 BARGAINING POWER OF BUYERS
           5.6.4 BARGAINING POWER OF SUPPLIERS
           5.6.5 INTENSITY OF COMPETITIVE RIVALRY
    5.7 REGULATORY ANALYSIS 
           5.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 5 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    5.8 PRICING ANALYSIS 
          TABLE 6 PRODUCT PRICING: KEY MARKET PLAYERS
           5.8.1 AVERAGE SELLING PRICE TREND
    5.9 KEY CONFERENCES AND EVENTS (2020–2023) 
          TABLE 7 SPATIAL GENOMICS AND TRANSCRIPTOMICS CONFERENCES (2020–2023)
    5.10 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
           5.10.2 BUYING CRITERIA FOR SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET IN ASIA PACIFIC REGION
                     FIGURE 20 KEY BUYING CRITERIA FOR END USERS
 
6 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT (Page No. - 44)
    6.1 INTRODUCTION 
          TABLE 8 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
    6.2 CONSUMABLES 
           6.2.1 GROWING USE OF CONSUMABLES FOR VARIOUS SPATIAL GENOMICS AND TRANSCRIPTOMICS APPLICATIONS TO DRIVE GROWTH
                    TABLE 9 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    6.3 INSTRUMENTS 
           6.3.1 INTRODUCTION OF NOVEL INSTRUMENTS TO DRIVE MARKET
                    TABLE 10 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    6.4 SOFTWARE 
           6.4.1 RISING USE OF SPATIAL OMICS FOR DISEASE DIAGNOSIS TO PROPEL DEMAND FOR SOFTWARE
                    TABLE 11 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
 
7 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE (Page No. - 48)
    7.1 INTRODUCTION 
          TABLE 12 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
    7.2 SPATIAL TRANSCRIPTOMICS 
          TABLE 13 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 14 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           7.2.1 IMMUNOHISTOCHEMISTRY
                    7.2.1.1 Emergence of mIHC/IF to propel growth
                                TABLE 15 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           7.2.2 IN SITU HYBRIDIZATION
                    7.2.2.1 High adoption of MERFISH to drive growth
                                TABLE 16 ASIA PACIFIC: IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           7.2.3 SPATIAL TRANSCRIPTOMIC SEQUENCING
                    TABLE 17 ASIA PACIFIC: SPATIAL TRANSCRIPTOMIC SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    7.2.3.1 Microdissection-based sequencing
                               7.2.3.1.1 Increasing use of microdissection-based sequencing to contribute to market growth
                    7.2.3.2 In situ sequencing
                               7.2.3.2.1 Increased adoption of in situ sequencing likely to boost market growth
                    7.2.3.3 Other sequencing technologies
           7.2.4 MICROSCOPY-BASED RNA IMAGING
                    7.2.4.1 Increasing use of microscopy-based RNA imaging in cancer research and diagnosis to drive growth
                                TABLE 18 ASIA PACIFIC: MICROSCOPY-BASED RNA IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           7.2.5 OTHER SPATIAL TRANSCRIPTOMICS TECHNIQUES
                    TABLE 19 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2020–2027 (USD MILLION)
    7.3 SPATIAL GENOMICS ANALYSIS 
          TABLE 20 ASIA PACIFIC: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 21 ASIA PACIFIC: SPATIAL GENOMICS ANALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           7.3.1 FLUORESCENCE IN SITU HYBRIDIZATION
                    7.3.1.1 Emerging potential of spatial genomics analysis in cancer diagnostics to support growth
                                TABLE 22 ASIA PACIFIC: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           7.3.2 SPATIAL GENOMIC SEQUENCING
                    7.3.2.1 Rising adoption of massively parallel sequencing to drive growth
                                TABLE 23 ASIA PACIFIC: SPATIAL GENOMIC SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           7.3.3 OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES
                    TABLE 24 ASIA PACIFIC: OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
 
8 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION (Page No. - 58)
    8.1 INTRODUCTION 
          TABLE 25 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
    8.2 TRANSLATIONAL RESEARCH 
           8.2.1 DEMAND FOR SPATIAL TRANSCRIPTOMICS IN UNDERSTANDING TUMOR MICROENVIRONMENT TO DRIVE GROWTH
                    TABLE 26 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION)
    8.3 DRUG DISCOVERY AND DEVELOPMENT 
           8.3.1 RISING USE OF RNA-SEQ IN DRUG DISCOVERY TO DRIVE GROWTH
                    TABLE 27 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION)
 
9 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER (Page No. - 62)
    9.1 INTRODUCTION 
          TABLE 28 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
    9.2 ACADEMIC AND RESEARCH INSTITUTES 
           9.2.1 INCREASING DEMAND FOR SPATIAL GENOMICS AND TRANSCRIPTOMICS IN TRANSLATIONAL RESEARCH TO DRIVE GROWTH
                    TABLE 29 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
    9.3 CONTRACT RESEARCH ORGANIZATIONS 
           9.3.1 INCREASING NUMBER OF CROS FORMING STRATEGIC PARTNERSHIPS WITH GENOMICS PROVIDERS TO DRIVE GROWTH
                    TABLE 30 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
    9.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 
           9.4.1 GROWING IMPORTANCE OF BIOMARKERS TO DRIVE DEMAND FOR SPATIAL GENOMICS AND TRANSCRIPTOMICS SYSTEMS
                    TABLE 31 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
 
10 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY COUNTRY (Page No. - 66)
     10.1 INTRODUCTION 
             TABLE 32 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
     10.2 CHINA 
             10.2.1 INCREASING R&D SPENDING BY GOVERNMENT AND BIOPHARMA COMPANIES TO SUPPORT MARKET GROWTH
                        TABLE 33 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                        TABLE 34 CHINA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 35 CHINA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 36 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                        TABLE 37 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 38 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
     10.3 JAPAN 
             10.3.1 RISING FUNDING IN JAPAN TO BOOST RESEARCH APPLICATIONS
                        TABLE 39 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                        TABLE 40 JAPAN: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 41 JAPAN: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 42 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                        TABLE 43 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 44 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
     10.4 INDIA 
             10.4.1 COLLABORATIONS BETWEEN HOSPITALS AND DIAGNOSTIC CENTERS FOR LABORATORY SERVICES TO BOOST GROWTH
                        TABLE 45 INDIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                        TABLE 46 INDIA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 47 INDIA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 48 INDIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                        TABLE 49 INDIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 50 INDIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
     10.5 REST OF ASIA PACIFIC 
             TABLE 51 REST OF ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
             TABLE 52 REST OF ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 53 REST OF ASIA PACIFIC: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 54 REST OF ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             TABLE 55 REST OF ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 56 REST OF ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
 
11 COMPETITIVE LANDSCAPE (Page No. - 78)
     11.1 INTRODUCTION 
     11.2 RIGHT-TO-WIN STRATEGIES ADOPTED BY KEY PLAYERS 
             FIGURE 21 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
     11.3 REVENUE SHARE ANALYSIS (TOP SIX PLAYERS) 
     11.4 MARKET SHARE ANALYSIS (2021) 
     11.5 COMPANY EVALUATION MATRIX 
             11.5.1 STARS
             11.5.2 EMERGING LEADERS
             11.5.3 PERVASIVE PLAYERS
             11.5.4 PARTICIPANTS
                       FIGURE 24 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: COMPANY EVALUATION MATRIX (2021)
     11.6 COMPETITIVE SCENARIO AND TRENDS 
             11.6.1 DEALS
                       TABLE 57 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: DEALS
                        11.6.1.1 Product launches
                                     TABLE 58 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: PRODUCT LAUNCHES
                        11.6.1.2 Other developments
                                     TABLE 59 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: OTHER DEVELOPMENTS
 
12 COMPANY PROFILES (Page No. - 86)
     12.1 KEY PLAYERS 
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
             12.1.1 NANOSTRING
                        TABLE 60 NANOSTRING: BUSINESS OVERVIEW
                        FIGURE 25 NANOSTRING: COMPANY SNAPSHOT (2021)
             12.1.2 10X GENOMICS
                        TABLE 61 10X GENOMICS: BUSINESS OVERVIEW
                        FIGURE 26 10X GENOMICS: COMPANY SNAPSHOT (2021)
             12.1.3 ILLUMINA
                        TABLE 62 ILLUMINA: BUSINESS OVERVIEW
                        FIGURE 27 ILLUMINA: COMPANY SNAPSHOT (2021)
             12.1.4 BIO-RAD LABORATORIES, INC.
                        TABLE 63 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
                        FIGURE 28 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2021)
             12.1.5 BIO-TECHNE
                        TABLE 64 BIO-TECHNE: BUSINESS OVERVIEW
                        FIGURE 29 BIO-TECHNE: COMPANY SNAPSHOT (2021)
             12.1.6 STANDARD BIOTOOLS
                        TABLE 65 STANDARD BIOTOOLS: BUSINESS OVERVIEW
                        FIGURE 30 STANDARD BIOTOOLS: COMPANY SNAPSHOT (2021)
             12.1.7 AKOYA BIOSCIENCES
                        TABLE 66 AKOYA BIOSCIENCES: BUSINESS OVERVIEW
                        FIGURE 31 AKOYA BIOSCIENCES: COMPANY SNAPSHOT (2021)
             12.1.8 S2 GENOMICS
                        TABLE 67 S2 GENOMICS: BUSINESS OVERVIEW
             12.1.9 CANTATA BIO
                        TABLE 68 CANTATA BIO: BUSINESS OVERVIEW
             12.1.10 VIZGEN CORP.
                        TABLE 69 VIZGEN: BUSINESS OVERVIEW
     12.2 OTHER PLAYERS 
             12.2.1 BGI GROUP
             12.2.2 MILTENYI BIOTEC
             12.2.3 BRUKER
             12.2.4 PERKINELMER INC.
             12.2.5 NOVOGENE CO., LTD.
 
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
 
13 APPENDIX (Page No. - 128)
     13.1 DISCUSSION GUIDE 
     13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     13.3 CUSTOMIZATION OPTIONS 
     13.4 RELATED REPORTS 
     13.5 AUTHOR DETAILS 

This study involved four major activities in estimating the current size of the Asia Pacific spatial genomics & transcriptomics market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the Asia Pacific spatial genomics & transcriptomics market. The secondary sources used for this study include Some of the key secondary sources referred to for this study include publications from government sources World Health Organization (WHO), National Institutes of Health (NIH), Organisation for Economic Co-operation and Development (OECD), International Agency for Research on Cancer (IARC), Research!America, Genome Canada, GenomeWeb, South African Medical Research Council (SAMRC), Wellcome Sanger Institute, Genome Research Limited, Labiotech.eu, R&D World Magazine, India Brand Equity Foundation (IBEF), Biotechnology Innovation Organization (BIO), National Center for Biotechnology Information (NCBI), BioPharm International, EvaluatePharma, ScienceDirect, Eurostat, Annual Reports, Press Releases, Investor Presentations, Expert Interviews, and MarketsandMarkets Analysis. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information.

APAC Spatial Genomics & Transcriptomics Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the Asia Pacific spatial genomics & transcriptomics market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and market have been identified through extensive secondary research
  • The revenues generated from the spatial genomics & transcriptomics business of leading players have been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the overall market size from the market size estimation process, the total market was split into several segments. To complete the overall market engineering process and arrive at the exact statistics for all segments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Report Objectives

  • To define, describe, and forecast the Asia Pacific spatial genomics & transcriptomics market based on product, technique, application, and end user.
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, challenges, opportunities, and trends)
  • To strategically analyse micromarkets with respect to individual growth trends, future prospects, and contributions to the overall spatial genomics & transcriptomics market
  • To analyse opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the spatial genomics & transcriptomics market.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Report Code
BT 8532
Published ON
Jan, 2023
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the APAC Spatial Genomics & Transcriptomics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2023 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback